Scholar Rock Holding (SRRK) Change in Account Payables (2017 - 2026)

Scholar Rock Holding's (SRRK) quarterly Change in Account Payables came in at -$1.1 million in Q1 2026, up 80.82% year-on-year from -$600032.3 in Q1 2025, and down 130.66% quarter-over-quarter from $3.5 million in Q4 2025.

Scholar Rock Holding (SRRK) Change in Account Payables (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Change in Account Payables history runs 10 years deep, the most recent figure standing at -$1.1 million for Q1 2026.

  • On a quarterly basis, Change in Account Payables rose 80.82% year-over-year to -$1.1 million in Q1 2026; TTM through Mar 2026 was $4.8 million, a 202.21% increase from a year earlier, with the FY2025 full-year figure at $208000.0, down 96.86% from the prior year.
  • Change in Account Payables retreated to -$1.1 million in Q1 2026 per SRRK's latest filing, from $3.5 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $6.0 million in Q4 2024 and bottomed at -$5.7 million in Q1 2025.
  • The 5-year median for Change in Account Payables is -$274000.0 (2023), against an average of $292529.4.
  • Biggest YoY gain for Change in Account Payables was 648.68% in 2025; the steepest drop was 827.54% in 2025.
  • Year by year, Change in Account Payables stood at $2.0 million in 2022, then dropped by 24.92% to $1.5 million in 2023, then surged by 302.4% to $6.0 million in 2024, then slumped by 41.25% to $3.5 million in 2025, then sank by 130.66% to -$1.1 million in 2026.
  • Per Business Quant, the three latest SRRK Change in Account Payables figures stand at -$1.1 million (Q1 2026), $3.5 million (Q4 2025), and $5.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -42.19 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.52 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 35.60 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 16.86 Mn
10 Scholar Rock Holding 6.30 Bn 6.30 Bn - -1.09 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.09 Mn
Mar 31, 2026 -1.09 Mn
Dec 31, 2025 3.54 Mn
Dec 31, 2025 3.54 Mn
Sep 30, 2025 5.66 Mn
Sep 30, 2025 5.66 Mn
Jun 30, 2025 -3.33 Mn
Jun 30, 2025 -3.33 Mn
Mar 31, 2025 -5.66 Mn
Mar 31, 2025 -5.66 Mn
Dec 31, 2024 6.02 Mn
Dec 31, 2024 6.02 Mn
Sep 30, 2024 756,000.00
Sep 30, 2024 756,000.00
Jun 30, 2024 460,000.00
Jun 30, 2024 460,000.00
Mar 31, 2024 -610,000.00
Mar 31, 2024 -610,000.00
Dec 31, 2023 1.50 Mn
Dec 31, 2023 1.50 Mn